Craig Berman's Colleagues at QED Therapeutics
Craig Berman's Contact Details
HQ
650-231-4088
650-231-4088
Location
Company
QED Therapeutics
QED Therapeutics
Craig Berman's Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Craig Berman
Craig Berman currently works for QED Therapeutics.
Craig Berman's role at QED Therapeutics is vice president clinical development.
Craig Berman's email address is ***@qedtx.com. To view Craig Berman's full email address, please signup to ConnectPlex.
Craig Berman works in the Biotechnology industry.
Craig Berman's colleagues at QED Therapeutics are Elena Muslimova, Dan Mulreany, Robyn Leary, Greg Troupe, Terry Cho, Hiywot MS, Devendra A. and others.
Craig Berman's phone number is ["+14153880465","+14157943870","+17209413775","+13033337841","+13193398665","+13193531551","+1970350